EKF Diagnostics Holdings plc
("EKF" or the "Company")
PDMR/Director Dealings
& Holding(s) in Company
EKF, the AIM-listed global diagnostics business, announces that the Board of EKF has been informed that on Thursday 28 April 2022, certain funds connected to Christopher Mills, Non-executive Chairman, purchased a total of 1,275,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 35 pence per Ordinary Share.
Following this transaction, Christopher Mills' total direct and indirect interest in the Company is 132,150,000 Ordinary Shares, representing approximately 29.04% of the total voting rights over the Company's issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below as is the Standard form for notification of major holdings received by EKF today.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers") |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Christopher Mills is the non-executive Chairman of the issuer and Chief Executive of the Investment Managers |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
EKF Diagnostics Holdings plc |
|||
|
b)
|
LEI
|
213800DXTF3EAUK1AR05
|
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of 1 pence each |
|||
|
|
|
||||
|
Identification code |
GB0031509804
|
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
0.35 |
1,275,000 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
N/A single transaction |
||||
|
|
|
||||
|
- Price |
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
28 April 2022 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange, AIMX |
|||
TR-1: Standard form for notification of major holdings
|
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i |
||||||
|
|
||||||
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: |
EKF DIAGNOSTICS HOLDINGS PLC |
|||||
|
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) |
||||||
|
Non-UK issuer |
|
|||||
|
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
||||||
|
An acquisition or disposal of voting rights |
X |
|||||
|
An acquisition or disposal of financial instruments |
|
|||||
|
An event changing the breakdown of voting rights |
|
|||||
|
Other (please specify) iii: |
|
|||||
|
3. Details of person subject to the notification obligation iv |
||||||
|
Name |
Harwood Capital Investment Management |
|||||
|
City and country of registered office (if applicable) |
Gibraltar |
|||||
|
4. Full name of shareholder(s) (if different from 3.) v |
||||||
|
Name |
Harwood Capital LLP North Atlantic Smaller Companies Investment Trust Plc Oryx International Growth Fund Limited |
|||||
|
City and country of registered office (if applicable) |
London, United Kingdom London, United Kingdom Guernsey, Guernsey |
|||||
|
5. Date on which the threshold was crossed or reached vi: |
28/04/2022 |
|||||
|
6. Date on which issuer notified (DD/MM/YYYY): |
29/04/2022 |
|||||
|
7. Total positions of person(s) subject to the notification obligation |
||||||
|
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer (8.A + 8.B) vii |
||
|
Resulting situation on the date on which threshold was crossed or reached |
29.04 |
0.00 |
29.04 |
132,150,000 |
||
|
Position of previous notification (if applicable) |
28.76 |
0.00 |
28.76 |
|
||
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii |
|||||||||
|
A: Voting rights attached to shares |
|||||||||
|
Class/type of ISIN code (if possible) |
Number of voting rights ix |
% of voting rights |
|||||||
|
Direct (DTR5.1) |
Indirect (DTR5.2.1) |
Direct (DTR5.1) |
Indirect (DTR5.2.1) |
||||||
|
GB0031509804 |
150,000 |
|
0.03 |
|
|||||
|
GB0031509804 |
96,000,000 |
|
21.10 |
|
|||||
|
GB0031509804 |
36,000,000 |
|
7.91 |
|
|||||
|
SUBTOTAL 8. A |
132,150,000 |
29.04% |
|||||||
|
|
|||||||||
|
B 1: Financial Instruments according to DTR5.3.1R (1) (a) |
|||||||||
|
Type of financial instrument |
Expiration |
Exercise/ |
Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights |
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
SUBTOTAL 8. B 1 |
|
|
|||||
|
|
|||||||||
|
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) |
|||||||||
|
Type of financial instrument |
Expiration |
Exercise/ |
Physical or cash Settlement xii |
Number of voting rights |
% of voting rights |
||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
|
|
|
SUBTOTAL 8.B.2 |
|
|
||||
|
|
|||||||||
|
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") |
||||
|
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii |
|
|||
|
Full chain of controlled undertakings through which the voting rights and/or the |
X |
|||
|
Name xv |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
|
Christopher Harwood Bernard Mills (Harwood Capital LLP) |
0.03 |
|
|
|
|
Christopher Harwood Bernard Mills (North Atlantic Smaller Companies Investment Trust plc) |
21.10 |
|
|
|
|
Christopher Harwood Bernard Mills (Oryx International Growth Fund Limited) |
7.91 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
10. In case of proxy voting, please identify: |
||||
|
Name of the proxy holder |
|
|||
|
The number and % of voting rights held |
|
|||
|
The date until which the voting rights will be held |
|
|||
|
|
||||
|
11. Additional information xvi |
||||
|
|
||||
|
Place of completion |
London Stock Exchange |
|
Date of completion |
28 April 2022 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.